Literature DB >> 21934205

Diagnostic utility of Ki67 and p53 immunostaining on solitary thyroid nodule--a cytohistological and radionuclide scintigraphic study.

Monisha Choudhury1, Smita Singh, Savita Agarwal.   

Abstract

BACKGROUND: For management of thyroid nodules, distinction between benign and malignant tumors is essential. Present study was undertaken to differentiate between benign and malignant lesions by using Ki-67 and p53 immunostaining and radionuclide perfusion scan.
MATERIALS AND METHODS: Study comprised of 25 prospective and 25 retrospective cases of solitary thyroid nodules. Fine needle aspiration was done on 25 prospective cases, which was correlated with histopathological diagnosis in 24 surgically excised cases. Immunostaining for p53 and Ki-67 was put on histopathological sections of 25 retrospective and 24 prospective cases. Radionuclide perfusion scan was performed and vascularity patterns were compared with their pathological nature to differentiate between benign and malignant nodule.
RESULTS: Cytohistological correlation was present in 80% of cases. On immunostaining, significant difference in mean value of Ki67 positivity was found between benign and malignant nodules (P < 0.05). On p53 immunostaining significant difference was observed in counts of benign and malignant lesions (P = 0.037). On radionuclide perfusion scan mean of difference between maximum and minimum perfusion activity between benign and malignant nodules was found to be statistically significant (P = 0.04), however there was no correlation between perfusion patterns and antigenic characteristics.
CONCLUSIONS: P53 and Ki-67 immunostaining along with radionuclide perfusion scan appears to be useful tools to differentiate between benign and malignant lesions in solitary thyroid nodule; however, more studies are needed to confirm this observation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934205     DOI: 10.4103/0377-4929.85077

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  7 in total

1.  Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.

Authors:  Smriti Sudhanshu Dwivedi; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Maithili Mandar Kulkarni; Pallavi Bhayekar; Amruta Jadhav; Musphera Nayar; Neelam S Kambale
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 2.  Molecular Markers in the Diagnosis of Thyroid Cancer in Indeterminate Thyroid Nodules.

Authors:  Subramanian Kannan
Journal:  Indian J Surg Oncol       Date:  2020-06-06

3.  Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: evaluation of oxidative stress and inflammatory markers.

Authors:  Natália Medeiros Dias Lopes; Hannah Hamada Mendonça Lens; Walison Augusto da Silva Brito; Julya Karen Bianchi; Poliana Camila Marinello; Rubens Cecchini; André Armani; Alessandra Lourenço Cecchini
Journal:  Clin Transl Oncol       Date:  2022-07-28       Impact factor: 3.340

4.  MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression.

Authors:  Xianzhao Deng; Bomin Guo; Youben Fan
Journal:  Onco Targets Ther       Date:  2021-01-18       Impact factor: 4.147

5.  An analysis of trends of incidence and cytohistological correlation of papillary carcinoma of the thyroid gland with evaluation of discordant cases.

Authors:  Chetna Sharma
Journal:  J Cytol       Date:  2016 Oct-Dec       Impact factor: 1.000

6.  The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?

Authors:  Jingdong Tang; Chunyi Gui; Shenglong Qiu; Min Wang
Journal:  World J Surg Oncol       Date:  2018-05-31       Impact factor: 2.754

7.  Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.

Authors:  Yue Jing; Yan Yang; Fengyao Hao; Yuxian Song; Xiaoxin Zhang; Ye Zhang; Xiaofeng Huang; Qingang Hu; Yanhong Ni
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.